Latest Memorial Sloan–Kettering Cancer Center Stories
An experimental drug that targets macrophages, a type of immune cells, in the microenvironment surrounding the lethal brain tumor glioblastoma multiforme decreased the cancer's growth and extended survival of laboratory mice with the cancer.
Scientific investigators at five institutions receive $1 million to spur better outcomes for patients with acral melanoma and provide breakthroughs through the use of genome sequencing.
For the first time, a genetic link specific to risk of childhood leukemia has been identified.
Hands On HealthCare Massage Therapy and Wellness Day Spa is raising awareness and funds during September, National
On September 27, the Mesothelioma Applied Research Foundation will be the host of its “Knowledge is Hope” regional conference on malignant mesothelioma, taking place at the Harvard Club in
A new study by thoracic surgeons and pathologists at Memorial Sloan-Kettering Cancer Center shows that a specific pattern found in the tumor pathology of some lung cancer patients is a strong predictor of recurrence.
- The act of lurking; skulking about; hiding; keeping from sight.